Rockwell Medical Statistics Share Statistics Rockwell Medical has 34.17M
shares outstanding. The number of shares has increased by 10.13%
in one year.
Shares Outstanding 34.17M Shares Change (YoY) 10.13% Shares Change (QoQ) 0.35% Owned by Institutions (%) 20.42% Shares Floating 28.72M Failed to Deliver (FTD) Shares 180 FTD / Avg. Volume 0.06%
Short Selling Information The latest short interest is 152.28K, so 0.45% of the outstanding
shares have been sold short.
Short Interest 152.28K Short % of Shares Out 0.45% Short % of Float 0.45% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -132 and the forward
PE ratio is -6.88.
Rockwell Medical's PEG ratio is
1.34.
PE Ratio -132 Forward PE -6.88 PS Ratio 0.62 Forward PS 0.4 PB Ratio 1.94 P/FCF Ratio 19.86 PEG Ratio 1.34
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Rockwell Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.63,
with a Debt / Equity ratio of 0.42.
Current Ratio 2.63 Quick Ratio 2.22 Debt / Equity 0.42 Debt / EBITDA 4.58 Debt / FCF 4.24 Interest Coverage 0.48
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $415.94K Profits Per Employee $-1.97K Employee Count 244 Asset Turnover 1.71 Inventory Turnover 14.54
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -60.5% in the
last 52 weeks. The beta is 1.63, so Rockwell Medical's
price volatility has been higher than the market average.
Beta 1.63 52-Week Price Change -60.5% 50-Day Moving Average 0.99 200-Day Moving Average 1.69 Relative Strength Index (RSI) 44.7 Average Volume (20 Days) 287,417
Income Statement In the last 12 months, Rockwell Medical had revenue of 101.49M
and earned -480K
in profits. Earnings per share was -0.01.
Revenue 101.49M Gross Profit 17.48M Operating Income 608K Net Income -480K EBITDA 2.95M EBIT 774K Earnings Per Share (EPS) -0.01
Full Income Statement Balance Sheet The company has 15.66M in cash and 13.54M in
debt, giving a net cash position of 2.13M.
Cash & Cash Equivalents 15.66M Total Debt 13.54M Net Cash 2.13M Retained Earnings -397.68M Total Assets 53.96M Working Capital 21.83M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 4.2M
and capital expenditures -1.01M, giving a free cash flow of 3.19M.
Operating Cash Flow 4.2M Capital Expenditures -1.01M Free Cash Flow 3.19M FCF Per Share 0.1
Full Cash Flow Statement Margins Gross margin is 17.23%, with operating and profit margins of 0.6% and -0.47%.
Gross Margin 17.23% Operating Margin 0.6% Pretax Margin -0.47% Profit Margin -0.47% EBITDA Margin 2.91% EBIT Margin 0.6% FCF Margin 3.14%
Dividends & Yields RMTI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for RMTI is $4,
which is 325.5% higher than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference 325.5% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 13, 2022. It was a
backward
split with a ratio of 1:11.
Last Split Date May 13, 2022 Split Type backward Split Ratio 1:11
Scores Altman Z-Score -7.14 Piotroski F-Score 4
